Substitution of the side-chain-constrained amino acids beta-methyl-2 ＇,6 ＇-dimethyl-4 ＇-methoxytyrosine in position 2 of a bicyclic oxytocin analogue provides unique insights into the bioactive topography of oxytocin antagonists